Specific Immunotherapy in LAR: a randomized, double ‐blind placebo controlled trial with Phleum pratense subcutaneous allergen immunotherapy

ConclusionsSubcutaneous immunotherapy with depigmented‐polymerized allergen extracts is a safe and clinically effective treatment for LAR to Phleum pratense.clinicaltrials. gov identifier: NCT02126111.This article is protected by copyright. All rights reserved.

Source: Allergy - November 23, 2017 Category: Allergy & Immunology Authors: Carmen Rond ón, Natalia Blanca‐López, Paloma Campo, Cristobalina Mayorga, Raquel Jurado‐Escobar, Maria J Torres, Gabriela Canto, Miguel Blanca Tags: Original Article: Airway Diseases Source Type: research